Hemophilia a patients with inhibitors: Mechanistic insights and novel therapeutic implications
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.1019275
Abstract: The development of coagulation factor VIII (FVIII) inhibitory antibodies is a serious complication in hemophilia A (HA) patients after FVIII replacement therapy. Inhibitors render regular prophylaxis ineffective and increase the risk of morbidity and mortality.… read more here.
Keywords: hemophilia patients; inhibitors mechanistic; novel therapeutic; insights novel ... See more keywords